Tuesday, November 16, 2010

HPV Predicts Survival In Tonsil And Tongue Cancers


Main Category: Cervical Cancer / HPV Vaccine
Also Included In: Cancer / Oncology
Article Date: 03 Nov 2010 - 4:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
When the human papillomavirus (HPV) is found in cancer tumours of the tonsil and base of the tongue, patients are more likely to survive following treatment.

The new research1, published in the British Journal of Cancer and during Mouth Cancer Awareness Month, followed 198 patients in Australia for an average of two years after they had had surgery or radiotherapy for the disease.

The researchers found that patients with HPV positive cancer were four times less likely to die than patients whose cancers weren't caused by the HPV infection.

The cancer was also three times less likely to recur at the primary site in patients with HPV positive cancers.

Dr Angela Hong, lead author from the University of Sydney, said: "Our study, which focused on a group of patients with advanced oropharyngeal cancer, found that those with cancer caused by HPV had a significantly better chance of survival than cancer which was not caused by HPV. And this beneficial HPV effect was seen regardless of the type of treatment they had.

"HPV status is now the strongest predictor of whether a patient will survive oropharyngeal cancer or whether the disease will return. Various clinical trials are now in development to tailor treatment according to HPV status of tumours."

Dr Lesley Walker, director of information at Cancer Research UK, said: "This study suggests that people with HPV in tumours of tonsil and base of tongue cancers respond better to treatment. It's possible that, in the future, patients with HPV positive cancers may be able to have less intensive forms of treatment which would reduce the side effects of therapy.

"In addition to its role in cancer of the oropharynx, HPV causes most if not all cervical cancer and increases the risk of cancer of the vagina, penis and anus. The virus is spread through all types of close sexual contact but using condoms and vaccination against HPV will reduce the risk.

"Smoking and drinking alcohol also increase the chance of developing head and neck cancer. People can reduce their risk by not smoking, cutting down on their alcohol intake and by eating a healthy balanced diet which is high in fruit and vegetables."

Reference

1. Hong et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy, British Journal of Cancer (2010) 00, 1-8

Source:
Cancer Research UK

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Read More ..

Decisions On Health Law's Fate Start Today As GOP Seems Poised For Gains


Main Category: Public Health
Article Date: 03 Nov 2010 - 4:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated

Politico: "Expected Republican wins in Congress and in statehouses throughout the country Tuesday would likely slow down implementation of the law and make the debate even more contentious - but not outright stop the law. ... several of the Republicans poised to take up key committee gavels promise to use their subpoena power to seek White House records of the legislative battle and call the administration to Capitol Hill to defend the law. They hope to use the next two years of congressional oversight to make the case for repealing the law in 2012 with a Republican president." GOP leaders have recently tried to temper expectations that an outright repeal would be forthcoming, if they're in the majority (Haberkorn, 11/2).

The Washington Post, in an analysis, notes that Republicans "almost certainly wouldn't have the votes to overwhelm a Democratic filibuster, much less overturn a presidential veto. The law, most likely, is here to stay. ... [But] the health-care law needs appropriations. The bill specifically details about 115 of them, some of which are integral to implementation of the legislation. Moreover, Republicans could get even more creative, refusing, for instance, to allow the Department of Health and Human Services to spend staff time setting up the law." But the repeal try through appropriations could be a double-edged sword for Republicans: If Obama refused to sign appropriations bills without funding for implementation of the health law, it could lead to a government shut down, harming the GOP (Klein, 11/1).

Related, earlier KHN story: House Takeover Would Give GOP Ways To Attack Health Law (Werber Serafini, 10/31)

The Wall Street Journal: Meanwhile, "health-industry groups, which aligned themselves with Democrats to pass the overhaul, are now reaching out to Republicans to help shape the GOP's health-care agenda. Insurers want to reverse tax increases and loosen restrictions on insurance premiums, and several groups hope to tack on medical malpractice protections." But insurers remain worried that the GOP will remove the individual mandate on Americans to purchase health insurance and "[m]ost health-industry groups - including [Karen] Ignagni's insurance group [America's Health Insurance Plans], which criticized the final law - say they're not ready to take a position on the Republicans' repeal effort" (Adamy and Weisman, 11/1).

The Wall Street Journal, in a separate story, reports that governors races are likely to influence the debate as well. "It is at the state level that the rubber of the health overhaul passed earlier this year actually hits the road. The law requires states by 2014 to set up exchanges through which citizens can buy health insurance. The details, however, are largely left to states. ... That may make friendlier conditions for health-care companies as they look to 2014. Right-leaning states aren't only expected to set up smaller, less ambitious exchanges, but could add to private insurers' rolls by shrinking public programs like Medicaid. Little wonder shares of some large health providers, like UnitedHealth Group Inc., have rallied by more than a quarter since July." Health care companies still face challenges, however, as parts of the health law are implemented (11/2).

Los Angeles Times: Meanwhile, TV's "Dr. Oz" says it's time for people to "get over it" and use the new health law. The "nonpartisan California Endowment, a leading advocate of the new law" is planning to air a new advertisement on California television stations after the election ends Tuesday that will feature Dr. Mehmet Oz urging residents there to make the health law work. "'The party's over,' Oz says as the commercial begins. 'Whether your side won or lost, the yelling season is through. It's time to get over it and get on with it.'" The ad buy is $1 million (Levey, 11/1).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Read More ..

SNA Joins American Dietetic Association And SNE In Affirming The Importance Of Schools In Improving Child Nutrition And Health


Main Category: Nutrition / Diet
Also Included In: Pediatrics / Children's Health
Article Date: 03 Nov 2010 - 4:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
3 starsnot yet rated
As Congress, First Lady Michelle Obama and communities across the country seek ways to address the deepening childhood obesity crisis, three leading organizations in the field of nutrition have united to emphasize the importance of schools in promoting healthy lifestyles for children.

The School Nutrition Association (SNA) has joined the American Dietetic Association (ADA) and Society for Nutrition Education (SNE) in releasing a position paper in support of comprehensive, integrated nutrition services in K-12 schools. The paper, published today in the November issue of the Journal of the American Dietetic Association, affirms the key role schools can play in improving the nutrition, health and academic performance of America's children. The paper will also run later this month in SNA's publication, The Journal of Child Nutrition & Management.

The organizations, updating a 2003 joint position paper, also cite the tremendous potential for local school wellness policies to strengthen comprehensive nutrition services within schools by bringing together key players throughout the community to address the school needs on multiple fronts.

The position paper was written by registered dietitians Marilyn Briggs, PhD, RD, SNS (ADA); Constance G. Mueller, MS, RD, SNS (SNA); and Sheila Fleischhacker, PhD, JD (SNE).

Source:
School Nutrition Association

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

posted by bill vest on 3 Nov 2010 at 4:08 pm

Sisu is a Scandinavian word meaning intestinal fortitude or "guts". Hats off to these three powerhouses that are teaming up to dive into a problem that takes true grit to tackle. Childhood obesity didn't happen over night and we have to put our best feet forward to change the devestation that it is causing throughout our nation. Our commitment has to be collective! There are excellent tools that have been developed to assist each of us in our quest to conquer this worldwide problem. We've got "sisu" to jump on the band wagon to a healthier environment! How about you?

| post followup | alert a moderator |


All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Read More ..

Monday, November 15, 2010

The Final Taboo: Millions Of Employees Forced To Lie About Stress, UK


Main Category: Anxiety / Stress
Also Included In: Mental Health;  Psychology / Psychiatry
Article Date: 03 Nov 2010 - 5:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
5 starsnot yet rated
Millions of British workers feel forced to lie to their bosses about having to take stress-induced sick leave, research reveals.

A study by leading mental health charity Mind, released to coincide with Stress Awareness Day (3 November), finds that talking about workplace pressures remains a huge taboo.

Stress has forced one in five workers (19 per cent) to call in sick, yet the vast majority of these (93 per cent) say they have lied to their boss about the real reason for not turning up, citing everything from stomach upsets, housing problems and the illness of a loved one as reasons for their absence.

However, few employees actually want to hide their stress levels from their bosses - 70 per cent wanted to be able to discuss stress with their employers, and one third want their boss to make the first move and approach them directly when they are showing signs of strain.

Paul Farmer, Chief Executive of Mind said: Millions of people experience unmanageable stress at work, and the fact that so many people feel forced to lie about it rather than finding a solution should be a major concern for our businesses. If employees don't feel they can be honest about the pressures on them, problems that aren't addressed can quickly snowball into low morale, low productivity and high sick leave. We'd urge employers to encourage a culture of openness at work so they can solve problems now, rather than storing up problems for the future.

The Mind research also reveals that the majority of employees (62 per cent) feel their bosses aren't doing enough to look after the workplace wellbeing of their staff, which may explain why stress has made one in five workers (21 per cent) physically ill and driven a further one in 10 into counselling.

And employers who ignore the problem of stress in their workplace could be putting their businesses in jeopardy. Previous figures show that businesses are losing an estimated £8.4bn (1) through sick days caused by poor mental wellbeing.

Paul Farmer continued: Stress can be a taboo word in many workplaces, but pretending the problem isn't there only makes things worse. Looking after stress levels and promoting a mentally healthy workplace reduces sick leave, helps staff to stay productive and ultimately saves hard-pressed businesses money. In the current climate, it will be increasingly hard for businesses to prosper with an unhappy and stressed workforce, so it's vital they work with their employees to discuss pressures on staff before they escalate.

When pressure is high, managers need to spend more time on leading and managing people, not less. Taking time out with an employee can seem like an extra burden for managers with their own set of targets to meet, but supporting staff properly will reduce absence, improve performance and benefit the company as a whole. The top five lies employees use when covering up their stress are:

Stomach upset - 36%
A cold - 13%
A headache - 12%
A medical appointment - 6%
Bad back - 5%

Mind is currently campaigning to tackle workplace stress and make workplaces more mentally healthy through its "Taking care of business" campaign.

Mind's guide for employers to tackle stress

- Manage workloads among your staff. Make sure that no one is expected to deliver more than what they are capable of.

- Train managers to identify risks, recognise stress and support their staff.

- For staff working in isolation, ensure there are clear and regular lines of communication. A monthly team meeting or a regular phone catchup will keep you in contact with these members of staff and enable you to prevent problems from occurring.

- Offer stress coaching and on-the-job support. Start a mentoring scheme to help new members of staff understand your organisation faster and to support them in their role. Or you could start a buddy system which enables colleagues to support other colleagues outside the official line-management structure.

- Make sure that work environments are suitable for the task. Noise, temperature and light levels can all have a big impact on wellbeing. Could space dividers, quiet spaces or music improve your workplace?

Source:
MIND

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Read More ..

NASDAQ Grants Cell Therapeutics 180-Day Extension To Regain Compliance With Minimum Bid Price Rule


Main Category: Pharma Industry / Biotech Industry
Article Date: 03 Nov 2010 - 5:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that The NASDAQ Stock Market ("NASDAQ") has granted CTI an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5550(a)(2)). Previously, on May 3, 2010, CTI was notified by NASDAQ that CTI did not meet the minimum bid price rule required for continued listing and was provided until November 1, 2010 to achieve compliance.

CTI may achieve compliance during the 180-day period if the closing bid price of CTI's common stock is at least a $1.00 per share for a minimum of 10 consecutive business days before May 2, 2011.

Source:
Cell Therapeutics, Inc.

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Read More ..

Phase I Radiation Oncology Clinical Trials Are More Toxic Than Suspected


Main Category: Cancer / Oncology
Also Included In: Radiology / Nuclear Medicine;  Clinical Trials / Drug Trials
Article Date: 03 Nov 2010 - 3:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
1 starnot yet rated
Risks to patients enrolled in Phase I radiation oncology clinical trials are higher than previously appreciated, according to a study conducted by researchers from the Kimmel Cancer Center at Jefferson. The findings will be presented at the American Society of Radiation Oncology (ASTRO) annual meeting in San Diego.

The researchers, who reviewed 102 radiation oncology phase I clinical trials conducted around the world, found the risk of major toxicity was significant there were four major toxic events for every 10 patients treated. The risk of death, however, was low at less than one percent.

"We had anticipated risk of serious toxicity to be around 10 percent, so we were surprised, and concerned, to find the actual risk is significantly higher," says the study's senior investigator, radiation oncologist Yaacov Richard Lawrence, M.R.C.P., assistant professor at Thomas Jefferson University. "Although high, the risk is very similar to that patients encounter when they enter phase I trials that do not involve radiation."

The findings are important because they can be used to provide a truer sense of risk to patients who enroll in these clinical trials, he says. "Before entering a trial patients sign an informed consent that explains benefits and risks, so it is important for us and for our patients to have a truer picture of these risks."

They also suggest that designs and reporting of phase I radiation oncology clinical trials should be more consistent, says Dr. Lawrence. "The nature of these trials is that it is much easier to quantify risk than potential benefits."

The findings are being presented at ASTRO by co-author Robert Den, M.D., a resident within the radiation oncology department. Much of the work was performed by Charles Glass, a fourth year medical student.

The research team examined phase I and phase I/II clinical trials published between 2001 and 2009 that included radiation therapy. Many of these trials involved combining radiation with cytotoxic agents (such as chemotherapy) or with biologic drugs. Most of the trials (59 percent) were performed in the U.S., 66 percent were multinational, 17 percent were conducted by a cooperative research group, 68 percent were phase I and 32 percent were phase I/II. The majority of the trials (71) involved dose escalating the chemotherapeutic or biologic agent delivered with radiotherapy; 21 trials tested dose escalation of radiotherapy alone, two trials escalated both radiotherapy and/or a chemotherapeutic agent, and eight trials involved radiotherapy that was not dose escalated.

The trials involved lung (22 percent), brain (12 percent), rectum (11 percent), and head and neck (11 percent) cancers.

In all, 4,553 patients were enrolled in these studies. After a median follow-up of more than two years, there were a total of 39 treatment-related deaths, and 1,881 major acute toxicities (defined as grade 3 or worse).

Still, it is important to remember that "patients enter phase I trials because they are facing a serious problem and hence need to balance the perceived risks with the potential benefits," says Adam Dicker, MD, PhD, Professor and Chairman of the Department of Radiation Oncology at Jefferson.

The majority of side effects were seen in studies that tested use of a combination of chemotherapy and radiation at the same time, Dr. Lawrence says. "We may not see as much toxicity from this point on, because most clinical trials today are looking at newer less toxic medicines," he says.

There was no external funding for this study.

Source: Thomas Jefferson University

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Read More ..

  © Blog design by Jasa Adsense 2010

Back to TOP